The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Plasma asparaginase activity and asparagine depletion in patients with acute lymphoblastic leukemia (ALL) treated with pegaspargase (SS-PEG E. coli L-asparaginase): Results from Children’s Oncology Group (COG) study AALL07P4.
 
Reuven J. Schore
Honoraria - Baxalta
Research Funding - Merck Sharp & Dohme (Inst); Millennium (Inst); Onyx (Inst)
 
Meenakshi Devidas
No Relationships to Disclose
 
Archie Bleyer
Honoraria - Jazz Pharmaceuticals; Sigma-Tau
Consulting or Advisory Role - Sigma-Tau
Speakers' Bureau - Sigma-Tau
 
Gregory H. Reaman
No Relationships to Disclose
 
Naomi J. Winick
No Relationships to Disclose
 
Mignon L. Loh
No Relationships to Disclose
 
Elizabeth A. Raetz
No Relationships to Disclose
 
William L. Carroll
No Relationships to Disclose
 
Stephen Hunger
Stock and Other Ownership Interests - Amgen; Amgen (I); Express Scripts; Merck (I); Pfizer (I)
Honoraria - Jazz Pharmaceuticals; Sigma-Tau; Spectrum Pharmaceuticals
Patents, Royalties, Other Intellectual Property - I am a co-Inventor on a US patent #8,568,974 B2 Identification of novel subgroups of high-risk pediatric precursor-B acute lymphoblastic leukemia, outcome correlations and diagnostic and therapeutic methods related to same. It has not be licensed and ther
Travel, Accommodations, Expenses - Amgen
 
Anne L. Angiolillo
No Relationships to Disclose